Tyra Biosciences, Inc.
Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast…
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
Tyra Biosciences, Inc. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
Tyra Biosciences, Inc. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of Tyra Biosciences, Inc..